Literature DB >> 7695975

Post-irradiation soft tissue sarcoma.

C Bloechle1, M Peiper, R Schwarz, S Schroeder, C Zornig.   

Abstract

From 1975 to 1993, 11 of 375 patients treated for soft tissue sarcoma presented with post-irradiation sarcoma. The mean time interval between irradiation therapy and onset of the second neoplasm was 15.8 years (4-31 years). The total radiation dosage ranged from 12 to 60 Gy with a mean of 40 Gy. All patients had complete staging including CT or MRI of the tumour site, and CT of the lung. Surgical resection was the treatment of choice. Wide margins could be achieved in 10 patients. One had a marginal resection. Tumours included malignant fibrous histiocytoma, haemangiosarcoma, rhabdomyosarcoma, malignant schwannoma, fibrosarcoma and undifferentiated sarcoma. All patients were reassessed in our outpatient clinic. After a mean follow-up of 4.7 years (1.0-11.5 years), only 1 patient had died because of the tumour. Although post-irradiation sarcomas are rather infrequently observed, these tumours must be suspected when alterations or symptoms occur in a previously irradiated region. Early detection provides the chance of curative, wide margin resection.

Entities:  

Mesh:

Year:  1995        PMID: 7695975     DOI: 10.1016/0959-8049(94)00378-i

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  10 in total

Review 1.  Efficacy and toxicity of radiation in preparative regimens for pediatric stem cell transplantation. II: Deleterious consequences.

Authors:  T D Miale; S Sirithorn; S Ahmed
Journal:  Med Oncol       Date:  1996-03       Impact factor: 3.064

Review 2.  [Hemangiosarcoma after breast-conserving therapy of breast cancer: report of four cases with molecular genetic diagnosis and literature review].

Authors:  Carolin Nestle-Krämling; Edwin Bölke; Wilfried Budach; Matthias Peiper; Dieter Niederacher; Wolfgang Janni; Claus Ferdinand Eisenberger; Wolfram Trudo Knoefel; Axel Scherer; Stephan Ernst Baldus; Guido Lammering; Peter Arne Gerber; Christiane Matuschek
Journal:  Strahlenther Onkol       Date:  2011-08-16       Impact factor: 3.621

3.  Development of primary leiomyosarcoma of the sternum postirradiation: report of a case.

Authors:  T Aoki; Y Ozeki; M Watanabe; S Tanaka; H Isaki; S Terahata
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

4.  Radiation-induced sarcoma of the breast: a systematic review.

Authors:  Grishma R Sheth; Lee D Cranmer; Benjamin D Smith; Lauren Grasso-Lebeau; Julie E Lang
Journal:  Oncologist       Date:  2012-02-14

Review 5.  [Radiotherapy of soft tissue sarcoma--part of a multidisciplinary strategy].

Authors:  Hildegard Pape; Klaus Orth; Rainer Engers; Christiane Matuschek; Anja Müller; Karl-Axel Hartmann; Peter Arne Gerber; Guido Lammering; Daniel Habermehl; Roland Fenk; Wilfried Budach; Stephan Gripp; Matthias Peiper; Edwin Bölke
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

6.  Radiation-Induced Intraspinal Chondrosarcoma: A Case Report.

Authors:  Peter Obid; Mathias Vierbuchen; Eduard Wolf; Michael Reichl; Thomas Niemeyer; Hüseyin Übeyli; Alexander Richter
Journal:  Global Spine J       Date:  2015-02-25

7.  [Progressive paralysis caused by radiation-induced cervical malignant peripheral nerve sheath tumor].

Authors:  J T Siveke; R Sen Gupta; K U Rieckhoff; D Braumann; T Goldmann
Journal:  HNO       Date:  2003-04-11       Impact factor: 1.284

8.  Pelvic Radiation-Induced Sarcoma With Rhabdomyoblastic Differentiation Following Treatment of Cervical Cancer.

Authors:  Shahd S Almohsen; Hala Alnuaim; Alaa A Salim; Haitham Arabi
Journal:  Cureus       Date:  2021-06-03

9.  Should cancer survivors fear radiation-induced sarcomas?

Authors:  M Feigen
Journal:  Sarcoma       Date:  1997

10.  Metachronous Bilateral Extremity Soft Tissue Sarcomas.

Authors:  Ghodratollah Nowrasteh; Tanim Aziz; Mohammed Al Assas; Lateefa Al Nuaimi; Saeeda Marzouqi; Asif A M Quadri; Sadir Alrawi
Journal:  Am J Case Rep       Date:  2016-01-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.